Medicine for Preventing or Treating Enteritis and Intestinal Cancer
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Jan 30, 2025
app pub date -
Oct 28, 2022
filing date -
Oct 28, 2022
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Provided is a medicine for preventing or treating enteritis and intestinal cancer. Specifically, the present invention relates to a method for treating or preventing enteritis in a subject, preventing intestinal cancer in a subject, or activating Nrf2 and inhibiting NF-κB to reduce inflammation and oxidative damage caused by damage to the intestinal mucosa barrier of a subject, comprising administering to the subject an effective amount of an amniotic fluid or a pharmaceutical composition containing the amniotic fluid; the amniotic fluid comes from eggs at embryo ages of 5-12 days, eggs from birds other than chickens at the development stage corresponding to the development stage of chickens at said embryo age, embryos of rodents at a gestational age of 8-14 days, or embryos of non-human mammals other than rodents at the development stage corresponding to the development stage of rodents at a gestational age of 8-14 days.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully